Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,015 | 43,921 | 18,981 | 34,076 | 14,465 |
| Marketable Securities | 272,646 | 283,491 | 174,472 | 169,724 | 180,460 |
| Receivables | 42 | 167 | 219 | 284 | 668 |
| TOTAL | $308,251 | $330,034 | $197,415 | $207,321 | $198,784 |
| Non-Current Assets | |||||
| PPE Net | 1,356 | 1,484 | 1,533 | 1,672 | 1,689 |
| Investments And Advances | 56,453 | 40,556 | 33,502 | 35,561 | 53,170 |
| Other Non-Current Assets | 7,586 | 7,778 | 8,097 | 8,282 | 8,457 |
| TOTAL | $65,395 | $49,818 | $43,132 | $45,515 | $63,316 |
| Total Assets | $373,646 | $379,852 | $240,547 | $252,836 | $262,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 0 | 2,206 |
| Accounts payable and accrued liabilities | 4,170 | 3,593 | 3,068 | 1,645 | 1,662 |
| Accrued Expenses | 16,891 | 21,187 | 17,788 | 13,684 | 12,030 |
| TOTAL | $32,238 | $41,980 | $51,818 | $53,410 | $57,089 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,227 | 16,288 | 30,092 | 37,252 | 40,401 |
| Other Non-Current Liabilities | 8,705 | 9,002 | 9,286 | 9,563 | 9,832 |
| TOTAL | $8,705 | $9,931 | $27,098 | $30,038 | $35,468 |
| Total Liabilities | $40,943 | $51,911 | $78,916 | $83,448 | $92,557 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,598 | 65,546 | 58,098 | 49,202 | 47,966 |
| Common Shares | 66 | 60 | 49 | 49 | 48 |
| Retained earnings | -274,063 | -256,145 | -262,105 | -250,383 | -237,227 |
| Other shareholders' equity | -263 | 397 | -540 | -650 | -407 |
| TOTAL | $332,703 | $327,941 | $161,631 | $169,388 | $169,543 |
| Total Liabilities And Equity | $373,646 | $379,852 | $240,547 | $252,836 | $262,100 |